New molecular diagnostic methods in head and neck cancer

Head and Neck

Volumn 27, Issue 11, 2005, Pages 995-1003

  Rodrigo, Juan Pablo ^a,b   Ferlito, Alfio ^c   Suárez, Carlos ^a,b   Shaha, Ashok R ^d   Silver, Carl E ^e   Devaney, Kenneth O ^f   Bradley, Patrick J ^g   Bocker, Jennifer M ^e   McLaren, Kathryn M ^h   Grénman, Reidar ⁱ   Rinaldo, Alessandra ^c  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c UNIVERSITY HOSPITAL OF UDINE   (Italy)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f Foote Health System   (United States)

^g QUEEN S MEDICAL CENTRE   (United Kingdom)

^h ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

ⁱ TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Head and neck cancer; Molecular diagnostic methods; Molecular markers

Indexed keywords

CANCER DIAGNOSIS; CANCER GRADING; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; EARLY DIAGNOSIS; HEAD AND NECK CANCER; HISTOLOGY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; RADIOLOGY; REVIEW; RNA ANALYSIS;

DNA, NEOPLASM; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; PROTEOMICS; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 27644585239     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20257     Document Type: Review

References (62)

1. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001;345:1890-1900.
2. Kim MM, Califano JA. Molecular pathology of head-and-neck cancer. Int J Cancer 2004;112:545-553.
3. Leethanakul C, Knezevic V, Patel V, et al. Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol 2003;39:248-258.
4. Thompson AM. Dissecting the molecular mechanisms of human cancer: translating laboratory advances into clinical practice. Surg J R Coll Surg Edinb Irel 2004;2:1-6.
5. Cairns P, Sidransky D. Molecular methods for the diagnosis of cancer. Biochim Biophys Acta 1999;1423: C11-C18.
6. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin 1995;45:328-351.
7. Sidransky D, Von Eschenbach A, Tsai YC, et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991;252:706-709.
8. Mao L, Hruban RH, Boyle JO, Tockman M, Sidransky D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994;54:1634-1637.
9. Sidransky D, Boyle J, Koch W. Molecular screening. Prospects for a new approach. Arch Otolaryngol Head Neck Surg 1993;119:1187-1190.
10. Somers KD, Merrick MA, Lopez ME, Incognito LS, Schlechter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 1992;52:5997-6000.
11. Boyle JO, Mao L, Brennan JA, et al. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 1994;168:429-432.
12. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA 1994;91:9871-9875.
13. El-Naggar AK, Hurr K, Batsakis JG, Luna MA, Goepfert H, Huff V. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res 1995;55:2656-2659.
14. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-2492.
15. Nunes DN, Kowalski LP, Simpson AJ. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. Oral Oncol 2000; 36:525-528.
16. El-Naggar AK, Mao L, Staerkel G, et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas. Implications in molecular diagnosis and screening. J Mol Diagn 2001;3:164-170.
17. Sanchez-Cespedes M, Esteller M, Wu L, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 2000;60:892-895.
18. Rosas SL, Koch W, da Costa Carvalho MG, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001;61:939-942.
19. Mao L, El-Naggar AK, Fan YH, et al. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res 1996;56:5600-5604.
20. Patel MM, Parekh LJ, Jha FP, et al. Clinical usefulness of telomerase activation and telomere length in head and neck cancer. Head Neck 2002;24:1060-1067.
21. Fiedler W, Hoppe C, Schimmel B, et al. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers. Int J Mol Med 2002;9:417-423.
22. Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 2002;95: 1902-1910.
23. Kuropkat C, Plehn S, Herz U, Dunne AA, Renz H, Werner JA. Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer. Anticancer Res 2002;22:2221-2227.
24. Ranuncolo SM, Matos E, Loria D, et al. Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma. Cancer 2002;94: 1483-1491.
25. Katayama A, Bandoh N, Kishibe K, et al. Expressions of matrix metalloproteinase in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastasis and prognosis. Clin Cancer Res 2004;10: 634-640.
26. Ruokolainen H, Paakko P, Turpeenniemi-Hujanen T. Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis. Clin Cancer Res 2004;10:3110-3116.
27. Shah GV, Gandhi D, Mukherji SK. Magnetic resonance spectroscopy of head and neck neoplasms. Top Magn Reson Imaging 2004;15:87-94.
28. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 1994;73:187-190.
29. van Houten VMM, Tabor MP, van den Brekel MWM, et al. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions. Clin Cancer Res 2000;6:3803-3816.
30. Nathan CA, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Laryngoscope 2002;112:2129-2140.
31. Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727-1730.
32. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332: 429-435.
33. Tabor MP, Brakenhoff RH, van Houten VMM, et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001;7:1523-1532.
34. Nathan CA, Franklin S, Abreo FW, Nassar R, De Benedetti A, Glass J. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer. J Clin Oncol 1999;17: 2909-2914.
35. Goldenberg D, Harden S, Masayesva BG, et al. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130: 39-44.
36. Ferlito A, Rinaldo A, Robbins KT, et al. Changing concepts in the surgical management of the cervical node metastasis. Oral Oncol 2003;39:429-435.
37. Ambrosch P, Brinck U. Detection of nodal micrometastases in head and neck cancer by serial sectioning and immunostaining. Oncology (Huntingt) 1996;10: 1221-1226.
38. Ferlito A, Partridge M, Brennan J, Hamakawa H. Lymph node micrometastases in head and neck cancer: a review. Acta Otolaryngol 2001;121:660-665.
39. Ferlito A, Devaney KO, Robbins KT, Rinaldo A. Recommendations for studies on detection of neck disease [editorial]. Oral Oncol 2004;40:967-970.
40. Rinaldo A, Devaney KO, Ferlito A. Immunohistochemical studies in the identification of lymph node micrometastases in patients with squamous cell carcinoma of the head and neck. ORL J Otorhinolaryngol Relat Spec 2004;66: 38-41.
41. Niewenhuis EJ, Jaspars LH, Castelijns JA, et al. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates. Clin Cancer Res 2003;9:755-761.
42. Becker MT, Shores CG, Yu KK, Yarbrough WG. Molecular assay to detect metastatic head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130: 21-27.
43. Shores CG, Yin X, Funkhouser W, Yarbrough WG. Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:937-942.
44. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31: 11-24.
45. Ferris RL, Xi L, Raja S, et al. Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res 2005;65:2147-2156.
46. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
47. Chung CH, Parker JS, Karaca G, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004;5: 489-500.
48. Roepman P, Wessels LFA, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005;37:182-186.
49. Ferlito A. Distant metastases from head and neck cancer: a multi-institutional view. ORL J Otorhinolaryngol Relat Spec 2001;63:187-264.
50. Partridge M, Phillips E, Francis R, Li S-R. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC. J Pathol 1999;189:368-377.
51. Partridge M, Li S-R, Pateromichelakis S, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 2000;6:2718-2725.
52. Partridge M, Brakenhoff R, Phillips E, et al. Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure. Clin Cancer Res 2003;9:5287-5294.
53. Brakenhoff RH, Stroomer JGW, ten Brink C, et al. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction. Clin Cancer Res 1999;5:725-732.
54. Salesiotis AN, Cullen KJ. Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging. Curr Opin Oncol 2000;12: 229-239.
55. Quon H, Liu FF, Cummings BJ. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 2001;23:147-159.
56. Rodrigo JP, Suárez C, Ferlito A, Devaney KO, Petruzzelli GJ, Rinaldo A. Potential molecular prognostic markers for lymph node metastasis in head and neck squamous cell carcinoma. Acta Otolaryngol 2003;123:100-105.
57. Takes RP. Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers. Oral Oncol 2004;40:656-667.
58. Belbin TJ, Singh B, Barber I, et al. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 2002;62:1184-1190.
59. Ginos MA, Page GP, Michalowicz BS, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004;64:55-63.
60. Alevizos I, Mahadevappa M, Zhang X, et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 2001; 20:6196-6204.
61. Al Moustafa AE, Alaoui-Jamali MA, Batist G, et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002;21:2634-2640.
62. Hwang D, Alevizos I, Schmitt WA, et al. Genomic dissection for characterization of cancerous oral epithelium tissues using transcription profiling. Oral Oncol 2003; 39:259-268.